Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).

Donato Rigante; S Gaspari; Adele Compagnone; Achille Stabile

Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).

Donato Rigante
, S Gaspari
, Adele Compagnone
, Achille Stabile

Research output: Contribution to journal › Article

Abstract

A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.

Original language	English
Pages (from-to)	283-283
Number of pages	1
Journal	BONE
Volume	2007
Publication status	Published - 2007

Keywords

Anakinra

Cite this

@article{008145d8dfc14ffeb2c12c29a2b2bc43,

title = "Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).",

abstract = "A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.",

keywords = "Anakinra, Anakinra",

author = "Donato Rigante and S Gaspari and Adele Compagnone and Achille Stabile",

year = "2007",

language = "English",

volume = "2007",

pages = "283--283",

journal = "BONE",

issn = "1873-2763",

publisher = "New York : Elsevier Inc.",

}

TY - JOUR

T1 - Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).

AU - Rigante, Donato

AU - Gaspari, S

AU - Compagnone, Adele

AU - Stabile, Achille

PY - 2007

Y1 - 2007

N2 - A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.

AB - A child with CINCA syndrome has received a biologic treatment with anakinra, showing a paramount response at both clinical and laboratory level. In particular, the response of the skeletal signs of this disease is widely dicussed.

KW - Anakinra

UR - http://hdl.handle.net/10807/90820

M3 - Article

SN - 1873-2763

VL - 2007

SP - 283

EP - 283

JO - BONE

JF - BONE

ER -

Functional and structural improvement of knee arthropathy in CINCA syndrome under treatment with recombinant human interleukin-1 receptor antagonist (anakinra).

Abstract

Keywords

Other files and links

Fingerprint

Cite this